Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2000
11/07/2000US6143546 Nucleotide sequence that codes a proteolytic enzyme; for preparing bread products; for producing proteins and/or protein hydrosylates that give foods favorable flavors
11/07/2000US6143528 Forming rna-dna hybrids by reverse transcription, efficiently chemically binding a tag molecule to a diol present in the 5' cap site of messenger rna, separating hybrids carrying dna of correct length
11/07/2000US6143497 Synthesizing random oligomers on particles using identification tags to facilitate identification of sequence of monomers
11/07/2000US6143494 Nucleotide sequence which preferentially hybridizes and amplifies viral nucleic acid sequences; for detecting viral serotypes in a sample
11/07/2000CA2166981C Oncoprotein protein kinase
11/02/2000WO2000065041A1 Process for nucleic acid purification using silicon carbide
11/02/2000WO2000064988A1 Xanthene dyes and their application as luminescence quenching compounds
11/02/2000WO2000043493A8 Metalloproteinase adam 22
11/02/2000WO2000040758A3 Enhanced sequencing by hybridization using pools of probes
11/02/2000WO2000040590A3 Functionalised polynucleotide compound, optionally marked and method for detecting a target nucleic acid
11/02/2000EP1047942A1 Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors
11/02/2000EP1047784A2 Neissera meningitidis antigens
11/02/2000EP1047770A1 Histidine kinase
11/02/2000EP1047705A2 Nucleobase oligomers
11/01/2000CN1271733A CpG oligonucleotide with specific immunostimulation activity to human immune cell
10/2000
10/31/2000US6140496 Precursors for deoxyribonucleotides containing non-standard nucleosides
10/31/2000US6140494 Squarate dyes and their use in fluorescent sequencing method
10/31/2000US6140493 Method of synthesizing diverse collections of oligomers
10/31/2000US6140491 Enzymatic nucleic acid which cleaves ribonucleic acids; has hammerhead motif and has at least one sugar-sugar backbone linkage which is different from a phosphodiester linkage; more stable than ribozymes; antisense agents; viricides
10/31/2000US6140490 Pure and non-naturally occurring rna specific rna sequence and capable of binding to c1q; identified through selex method; for drugs which suppress and activate the complement system and for diagnostic agents
10/31/2000US6140489 Compositions for sorting polynucleotides
10/31/2000US6140482 Primary phosphoramidate internucleoside linkages and oligonucleotides containing the same
10/31/2000US6140480 Adduct of hoffer's chlorosugar comprising an organocadmium or organozinc derivative of pyrene, anthracene, phenanthrene, stilbene, tetracene, or pentacene coupled to the c1 position; fluorescent probes
10/31/2000US6140473 Antibodies specific for MTS2 Polypeptide
10/31/2000US6140466 Comprises at least three zinc finger domains that bind to target cellular nucleotide sequence and modulate its transcription; genome-specific transcriptional switches in gene therapy; transgenic plants and animals
10/31/2000US6140305 Hereditary hemochromatosis gene products
10/31/2000US6140125 Antisense inhibition of bcl-6 expression
10/31/2000US6140053 Determining a sequence of a nucleic acid
10/31/2000US6140051 Fluorescent dibenzazole derivatives and methods related thereto
10/31/2000US6140044 Methods and devices for packaging a substrate having an array of probes fabricated on its surface are disclosed
10/31/2000US6139835 Homologous recombination for allogeneic donor cells
10/26/2000WO2000063414A1 The rpoa gene of agrobacterium tumefaciens
10/26/2000WO2000063413A1 Agrobacterium tumefaciens rpoa gene
10/26/2000WO2000062605A1 eNOS MUTATIONS USEFUL FOR GENE THERAPY AND THERAPEUTIC SCREENING
10/26/2000WO2000013018B1 Support for a method for determining analytes and a method for producing the support
10/26/2000CA2369764A1 Enos mutations useful for gene therapy and therapeutic screening
10/25/2000EP1046649A1 Solid phase nucleic acid labeling by transamination
10/25/2000EP1046421A2 Methods and reagents for very large scale immobilized polymer synthesis
10/25/2000EP1045901A1 Ribozymal nucleic acids cleaving ccr5 or cxcr4
10/25/2000EP0751950B1 Method for identifying members of combinatorial libraries
10/25/2000EP0750626B1 Corpuscles of stannius protein, stanniocalcin
10/25/2000CN1271012A New human cation transfer related protein and its code sequence
10/25/2000CN1271011A New human phosphoric triesterase related protein and its code sequence
10/25/2000CN1271010A New human aromatic esterase protein and its code sequence
10/25/2000CN1271009A New human diacyl glyceropyrophosphate phosphatase protein and its code sequence
10/25/2000CN1271008A New human salt-resisting protein subunit protein and its code sequence
10/25/2000CN1271007A New human chitinase protein and its code sequence
10/25/2000CN1271006A New human proteinase subunit protein and its code sequence
10/25/2000CN1271005A New human cytochrome protein and its code sequence
10/25/2000CN1057774C 乙型肝炎疫苗 Hepatitis B Vaccine
10/24/2000US6138077 Method, apparatus and computer program product for determining a set of non-hybridizing oligonucleotides
10/24/2000US6136965 Deoxynucleic alkyl and alkoxy thiourea compounds
10/24/2000US6136792 Prostate specific enhancer polynucleotides and methods of use thereof
10/24/2000US6136787 Interleukin 1β protease and interleukin 1β protease inhibitors
10/24/2000US6136779 Methods of specifically transcriptionally modulating the expression of gene of interest
10/24/2000US6136601 Targeted mutagenesis in living cells using modified oligonucleotides
10/24/2000US6136583 Amidase
10/24/2000US6136529 Nucleic acid probes to Mycobacterium avium complex
10/24/2000US6136527 Polypeptides derived from proteins of the hepatitis C virus, test kits containing these polypeptides and vaccines against infections of hepatitis C viruses
10/24/2000US6136269 Combinatorial kit for polymer synthesis
10/24/2000CA2124814C 2'-deoxy-isoquanosines, isosteric analogues and isoquanosine derivatives as well as their use
10/24/2000CA2047702C Serpin resistant chymotrypsin superfamily proteases particularly pai-1 resistant t-pa, complementary inhibitor mutants; compositions; genes; expression
10/24/2000CA1341124C Genetic engineering process for the preparation of hirudins, and means for carrying out this process
10/19/2000WO2000061816A1 Electronically mediated nucleic acid amplification in nasba
10/19/2000WO2000061813A1 A second mammalian tankyrase
10/19/2000WO2000061621A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000WO2000061602A1 Antisense oligonucleotide modulation of stat3 expression
10/19/2000WO2000061597A1 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
10/19/2000WO2000061595A1 The novel antisense-oligos with better stability and antisense effect
10/19/2000WO2000061594A2 Nucleoside derivatives with photo-unstable protective groups
10/19/2000WO2000061151A2 Oligodeoxynucleotide and its use to induce an immune response
10/19/2000WO2000061069A2 Methods and compositions for use in the treatment of hyperlipidemia
10/19/2000WO2000026368A9 Therapeutic antiangiogenic endostatin compositions
10/19/2000DE19915867A1 New nucleoside derivatives with photolabile protecting groups, useful in oligonucleotide synthesis, particularly on solid phases, e.g. for hybridization testing
10/19/2000DE19914808A1 Informationstragende Polymere An information-carrying polymers
10/19/2000CA2372028A1 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000CA2370000A1 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
10/19/2000CA2369976A1 The novel antisense-oligos with better stability and antisense effect
10/19/2000CA2366657A1 Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip
10/19/2000CA2365996A1 Electronically mediated nucleic acid amplification in nasba
10/19/2000CA2360318A1 A second mammalian tankyrase
10/18/2000EP1045031A2 Amplification and detection of Yersinia enterocolitica
10/18/2000EP1045027A1 Novel gene having reverse transcriptase motif
10/18/2000EP1044987A2 Gapped 2'-modified oligonucleotides
10/18/2000CN1270598A Methods and compounds for analyzing nucleic acids by mass spectrometry
10/18/2000CN1270222A Human coenzyme I subunit isomer protein and its coding sequence
10/18/2000CN1270221A Human adenosine triphosphatase subunit protein and its coding sequence
10/18/2000CN1270220A Human protein related to VB12 and its coding sequence
10/18/2000CN1270173A Antisense thiooligonucleotide of targeting c-raf cancer gene, medicinal composition containing same, and application in treating cancers
10/18/2000CN1057534C Erythropoietin analogs
10/18/2000CN1057530C Fast extracting method of nucleic acid
10/17/2000US6133438 Alkylating unblocked cytidine to form 2'-o-alkylated cytidine, blocking the 5'-hydroxyl moiety, and phosphitylating the 3'-position
10/17/2000US6133436 Increased surface area for immobilization of nucleic acids; for use in hybridizations
10/17/2000US6133427 Anti-human calcitonin monoclonal antibodies and an immunoassay utilizing said antibodies
10/17/2000US6133246 Antisense oligonucleotide compositions and methods for the modulation of JNK proteins
10/17/2000US6133242 Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes
10/17/2000US6133038 Diagnostic kit includes container with platinum-based linker compound and container with detectable marker moiety; for preparation of labeled probes
10/17/2000US6133032 Antisense modulation of PI3 kinase p110 beta expression
10/17/2000US6133024 Recombinant vector which codes for an rna capable of forming a triple helix with target nucleic acid; for transcription of the rna in target cells
10/17/2000US6133012 Thermostable acyl peptide hydrolase and gene encoding the same